Amipharm Co., Ltd.

This was an early safety study of a new injection called AYP-101, designed to reduce fat under the chin. It tested a single dose in 26 healthy adults to see how their bodies processed the drug and to check for side effects. The main goal was to understand the safety and basic beh…

This completed Phase 3 study tested whether AYP-101 injections could safely reduce fat under the chin (double chin) in healthy adults. Researchers enrolled 252 participants with moderate to severe double chin fat and randomly assigned them to receive either the active injection o…